Palisade Bio (PALI) EBITDA Margin Growth (1y) (2012 - 2020)
Palisade Bio (PALI) EBITDA Margin Growth (1y) (2012 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -4.45 Mn |
| Sep 30, 2020 | 1.23 Mn |
| Jun 30, 2020 | -4.93 Mn |
| Mar 31, 2020 | 6.52 Mn |
| Dec 31, 2019 | -1.31 Mn |
| Sep 30, 2019 | -166,004.00 |
| Jun 30, 2019 | -2.35 Mn |
| Mar 31, 2019 | -430,280.00 |
| Dec 31, 2018 | -7.13 Mn |
| Sep 30, 2018 | 2.02 Mn |
| Jun 30, 2018 | 16.79 Mn |
| Mar 31, 2018 | 7.53 Mn |
| Dec 31, 2017 | 6.37 Mn |
| Sep 30, 2017 | 9.32 Mn |
| Jun 30, 2017 | -1.54 Mn |
| Mar 31, 2017 | 8.01 Mn |
| Dec 31, 2016 | 10.94 Mn |
| Sep 30, 2016 | 1.12 Mn |
| Jun 30, 2016 | 4.64 Mn |
| Mar 31, 2016 | -9.12 Mn |